Age-standardized incidence rates by sex, for (A) hepatitis B virus-attributable hepatocellular carcinoma; (B) hepatitis C virus-attributable hepatocellular carcinoma—Surveillance,... by Joy Jiang (5483006)

Subjects:

Prevalence of infection with (A) hepatitis B virus or (B) hepatitis C virus hepatocellular carcinoma among Medicare Part D beneficiaries, 2007–2017. by Joy Jiang (5483006)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Mean confidence in public health organizations among US adults. by Hannah Melchinger (20234665)

Subjects:

Percentage of US adults reporting high confidence in public health organizations. by Hannah Melchinger (20234665)

Subjects:

Incidence of (A) hepatitis B virus (HBV)-attributable hepatocellular carcinoma (HCC) and (B) hepatitis C virus (HCV)-attributable HCC in the SEER-Medicare population and frequency... by Joy Jiang (5483006)

Subjects:

Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

Age-standardized hepatocellular carcinoma (HCC) incidence rates, by viral hepatitis status, the surveillance, epidemiology, and end results–medicare database, 2007–2017. by Joy Jiang (5483006)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

National age-standardized rates of DALYs and ASDR of IHD attributable to HSBP and their estimated annual percentage changes in 2021. by Zhenhua Zhuang (11192745)

Age-specific estimated annual percentage changes in DALYs and death rates for 21 regions from 1990 to 2021. by Zhenhua Zhuang (11192745)

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Age-standardized hepatocellular carcinoma incidence rates among patients without viral hepatitis, by status for diabetes and/or obesity, alcohol-related liver disorders and rare ge... by Joy Jiang (5483006)

Subjects:

Average annual percent change (AAPC) with 95% confidence interval (CI) in age standardized hepatocellular carcinoma incidence rates per 100,000, overall and by hepatitis B virus (H... by Joy Jiang (5483006)

Subjects:

Characteristics of individuals with hepatocellular carcinoma, by hepatitis B virus (HBV) and hepatitis C virus (HCV) infection status, SEER-Medicare, 2007–2017. by Joy Jiang (5483006)

Subjects:

The distribution of <i>Giardia duodenalis</i> assemblages in domestic and wild populations of nonhuman mammalian species with a larger number of isolates. by Kareem Hatam-Nahavandi (7384790)

The estimation of the home range and core activity area of a female red panda released into the wild. by Yanshan Zhou (14131359)

Estimated trends of mortality rate (a, b) and ASMR (c, d) in 2030 (a, c) and 2050 (b, d) at the national level. by Qingsong Mao (19522438)

Estimated trends of DALYs Rate (a, b) and ASDR (c, d) in 2030 (a, c) and 2050 (b, d) at the national level. by Qingsong Mao (19522438)